HNRH3_HUMAN - dbPTM
HNRH3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HNRH3_HUMAN
UniProt AC P31942
Protein Name Heterogeneous nuclear ribonucleoprotein H3
Gene Name HNRNPH3
Organism Homo sapiens (Human).
Sequence Length 346
Subcellular Localization Nucleus .
Protein Description Involved in the splicing process and participates in early heat shock-induced splicing arrest. Due to their great structural variations the different isoforms may possess different functions in the splicing reaction..
Protein Sequence MDWVMKHNGPNDASDGTVRLRGLPFGCSKEEIVQFFQGLEIVPNGITLTMDYQGRSTGEAFVQFASKEIAENALGKHKERIGHRYIEIFRSSRSEIKGFYDPPRRLLGQRPGPYDRPIGGRGGYYGAGRGSMYDRMRRGGDGYDGGYGGFDDYGGYNNYGYGNDGFDDRMRDGRGMGGHGYGGAGDASSGFHGGHFVHMRGLPFRATENDIANFFSPLNPIRVHIDIGADGRATGEADVEFVTHEDAVAAMSKDKNNMQHRYIELFLNSTPGGGSGMGGSGMGGYGRDGMDNQGGYGSVGRMGMGNNYSGGYGTPDGLGGYGRGGGGSGGYYGQGGMSGGGWRGMY
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDWVMKHN
-------CCCCCCCC
9.15-
4 (in isoform 6)Phosphorylation-2.9724043423
6Sumoylation--MDWVMKHNGPNDA
--CCCCCCCCCCCCC
25.05-
6Acetylation--MDWVMKHNGPNDA
--CCCCCCCCCCCCC
25.0525825284
6Methylation--MDWVMKHNGPNDA
--CCCCCCCCCCCCC
25.05109061911
6Sumoylation--MDWVMKHNGPNDA
--CCCCCCCCCCCCC
25.0528112733
6Ubiquitination--MDWVMKHNGPNDA
--CCCCCCCCCCCCC
25.0521890473
7 (in isoform 6)Phosphorylation-26.7824043423
8 (in isoform 6)Phosphorylation-63.2024043423
10 (in isoform 6)Phosphorylation-40.6224043423
16 (in isoform 6)Phosphorylation-24.5024043423
17PhosphorylationPNDASDGTVRLRGLP
CCCCCCCCEEECCCC
13.88-
18 (in isoform 3)Ubiquitination-7.1121890473
19MethylationDASDGTVRLRGLPFG
CCCCCCEEECCCCCC
20.64115478855
19 (in isoform 6)Phosphorylation-20.6424043423
22 (in isoform 6)Phosphorylation-42.1524043423
24 (in isoform 6)Phosphorylation-26.8024043423
27 (in isoform 3)Ubiquitination-5.5621890473
28PhosphorylationRGLPFGCSKEEIVQF
CCCCCCCCHHHHHHH
43.4022777824
47PhosphorylationEIVPNGITLTMDYQG
EECCCCEEEEEEECC
19.99-
48 (in isoform 3)Ubiquitination-3.3621890473
49PhosphorylationVPNGITLTMDYQGRS
CCCCEEEEEEECCCC
10.19-
52PhosphorylationGITLTMDYQGRSTGE
CEEEEEEECCCCHHH
11.31-
57PhosphorylationMDYQGRSTGEAFVQF
EEECCCCHHHHHHHH
37.3721712546
66PhosphorylationEAFVQFASKEIAENA
HHHHHHHCHHHHHHH
31.9121712546
67AcetylationAFVQFASKEIAENAL
HHHHHHCHHHHHHHH
50.1126051181
67SumoylationAFVQFASKEIAENAL
HHHHHHCHHHHHHHH
50.1128112733
67UbiquitinationAFVQFASKEIAENAL
HHHHHHCHHHHHHHH
50.1121906983
67 (in isoform 1)Ubiquitination-50.1121890473
67 (in isoform 2)Ubiquitination-50.1121890473
76AcetylationIAENALGKHKERIGH
HHHHHHHHHHHHHCH
52.9725953088
76UbiquitinationIAENALGKHKERIGH
HHHHHHHHHHHHHCH
52.9721906983
76 (in isoform 1)Ubiquitination-52.9721890473
76 (in isoform 2)Ubiquitination-52.9721890473
78UbiquitinationENALGKHKERIGHRY
HHHHHHHHHHHCHHH
52.77-
90MethylationHRYIEIFRSSRSEIK
HHHHHHHHCCHHHHC
39.11115478863
91PhosphorylationRYIEIFRSSRSEIKG
HHHHHHHCCHHHHCC
21.2528348404
92PhosphorylationYIEIFRSSRSEIKGF
HHHHHHCCHHHHCCC
35.2528348404
97UbiquitinationRSSRSEIKGFYDPPR
HCCHHHHCCCCCCHH
38.6321890473
97 (in isoform 1)Ubiquitination-38.6321890473
97 (in isoform 2)Ubiquitination-38.6321890473
100PhosphorylationRSEIKGFYDPPRRLL
HHHHCCCCCCHHHHC
35.8928796482
110MethylationPRRLLGQRPGPYDRP
HHHHCCCCCCCCCCC
36.0281121133
116MethylationQRPGPYDRPIGGRGG
CCCCCCCCCCCCCCC
20.9224395495
116 (in isoform 2)Methylation-20.9224129315
121Asymmetric dimethylarginineYDRPIGGRGGYYGAG
CCCCCCCCCCCCCCC
30.10-
121MethylationYDRPIGGRGGYYGAG
CCCCCCCCCCCCCCC
30.1011152131
121 (in isoform 2)Methylation-30.1024129315
125PhosphorylationIGGRGGYYGAGRGSM
CCCCCCCCCCCCCHH
12.0825884760
129DimethylationGGYYGAGRGSMYDRM
CCCCCCCCCHHHHHH
33.22-
129MethylationGGYYGAGRGSMYDRM
CCCCCCCCCHHHHHH
33.2224383093
129 (in isoform 2)Methylation-33.2224129315
131 (in isoform 2)Phosphorylation-16.8926846344
132 (in isoform 2)Phosphorylation-4.4926846344
133PhosphorylationGAGRGSMYDRMRRGG
CCCCCHHHHHHHCCC
11.3325884760
135DimethylationGRGSMYDRMRRGGDG
CCCHHHHHHHCCCCC
11.74-
135MethylationGRGSMYDRMRRGGDG
CCCHHHHHHHCCCCC
11.7430762319
138MethylationSMYDRMRRGGDGYDG
HHHHHHHCCCCCCCC
44.0759080961
138 (in isoform 2)Phosphorylation-44.0726846344
141 (in isoform 2)Phosphorylation-56.1326846344
143PhosphorylationMRRGGDGYDGGYGGF
HHCCCCCCCCCCCCC
19.0222817900
144 (in isoform 2)Phosphorylation-49.9626846344
146 (in isoform 2)Phosphorylation-18.2726846344
147PhosphorylationGDGYDGGYGGFDDYG
CCCCCCCCCCCCCCC
21.4320090780
153PhosphorylationGYGGFDDYGGYNNYG
CCCCCCCCCCCCCCC
17.8122817900
156PhosphorylationGFDDYGGYNNYGYGN
CCCCCCCCCCCCCCC
8.8920090780
159PhosphorylationDYGGYNNYGYGNDGF
CCCCCCCCCCCCCCC
14.2122817900
161PhosphorylationGGYNNYGYGNDGFDD
CCCCCCCCCCCCCCC
11.4624043423
174MethylationDDRMRDGRGMGGHGY
CCCCCCCCCCCCCCC
35.8924129315
181PhosphorylationRGMGGHGYGGAGDAS
CCCCCCCCCCCCCCC
13.5020090780
188PhosphorylationYGGAGDASSGFHGGH
CCCCCCCCCCCCCCE
35.4229449344
189O-linked_GlycosylationGGAGDASSGFHGGHF
CCCCCCCCCCCCCEE
47.3928510447
189PhosphorylationGGAGDASSGFHGGHF
CCCCCCCCCCCCCEE
47.3927251275
200MethylationGGHFVHMRGLPFRAT
CCEEEEECCCCCCCC
28.72115478847
207PhosphorylationRGLPFRATENDIANF
CCCCCCCCCCHHHHH
30.9423403867
216PhosphorylationNDIANFFSPLNPIRV
CHHHHHCCCCCCEEE
25.0829255136
262PhosphorylationKNNMQHRYIELFLNS
CCCCCCEEEEEHHCC
9.1623663014
269PhosphorylationYIELFLNSTPGGGSG
EEEEHHCCCCCCCCC
37.8225159151
270PhosphorylationIELFLNSTPGGGSGM
EEEHHCCCCCCCCCC
25.5325159151
275PhosphorylationNSTPGGGSGMGGSGM
CCCCCCCCCCCCCCC
28.9623663014
280PhosphorylationGGSGMGGSGMGGYGR
CCCCCCCCCCCCCCC
21.6323663014
285PhosphorylationGGSGMGGYGRDGMDN
CCCCCCCCCCCCCCC
11.8523663014
287MethylationSGMGGYGRDGMDNQG
CCCCCCCCCCCCCCC
28.91-
290SulfoxidationGGYGRDGMDNQGGYG
CCCCCCCCCCCCCCC
5.2521406390
296PhosphorylationGMDNQGGYGSVGRMG
CCCCCCCCCCCCCCC
17.0427273156
298PhosphorylationDNQGGYGSVGRMGMG
CCCCCCCCCCCCCCC
16.9625159151
301MethylationGGYGSVGRMGMGNNY
CCCCCCCCCCCCCCC
19.1418600907
308PhosphorylationRMGMGNNYSGGYGTP
CCCCCCCCCCCCCCC
16.8218180459
309PhosphorylationMGMGNNYSGGYGTPD
CCCCCCCCCCCCCCC
28.0630576142
312PhosphorylationGNNYSGGYGTPDGLG
CCCCCCCCCCCCCCC
22.7318180459
314PhosphorylationNYSGGYGTPDGLGGY
CCCCCCCCCCCCCCC
15.1025159151
321PhosphorylationTPDGLGGYGRGGGGS
CCCCCCCCCCCCCCC
11.2320090780
323DimethylationDGLGGYGRGGGGSGG
CCCCCCCCCCCCCCC
31.90-
323MethylationDGLGGYGRGGGGSGG
CCCCCCCCCCCCCCC
31.9024129315
328PhosphorylationYGRGGGGSGGYYGQG
CCCCCCCCCCCCCCC
32.1121945579
331PhosphorylationGGGGSGGYYGQGGMS
CCCCCCCCCCCCCCC
14.1421945579
332PhosphorylationGGGSGGYYGQGGMSG
CCCCCCCCCCCCCCC
13.2721945579
338PhosphorylationYYGQGGMSGGGWRGM
CCCCCCCCCCCCCCC
37.2521945579
343DimethylationGMSGGGWRGMY----
CCCCCCCCCCC----
24.23-
343MethylationGMSGGGWRGMY----
CCCCCCCCCCC----
24.2324129315
346PhosphorylationGGGWRGMY-------
CCCCCCCC-------
20.4422210691

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of HNRH3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of HNRH3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HNRH3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ANX11_HUMANANXA11physical
16169070
PIM2_HUMANPIM2physical
16169070
RS4X_HUMANRPS4Xphysical
16169070
TTHY_HUMANTTRphysical
16169070
ERG28_HUMANC14orf1physical
16169070
KAT5_HUMANKAT5physical
16169070
UT14A_HUMANUTP14Aphysical
16169070
DPYL1_HUMANCRMP1physical
16169070
EF1G_HUMANEEF1Gphysical
16169070
ROA2_HUMANHNRNPA2B1physical
22939629
ROA1_HUMANHNRNPA1physical
22939629
HNRPR_HUMANHNRNPRphysical
22939629
SRSF1_HUMANSRSF1physical
22939629
HNRPF_HUMANHNRNPFphysical
22939629
SF3A3_HUMANSF3A3physical
22939629
HNRL1_HUMANHNRNPUL1physical
22939629
SNRPA_HUMANSNRPAphysical
22939629
SSBP_HUMANSSBP1physical
22939629
PUF60_HUMANPUF60physical
22939629
CHERP_HUMANCHERPphysical
22365833
ROA0_HUMANHNRNPA0physical
22365833
ROA1_HUMANHNRNPA1physical
22365833
NCBP3_HUMANC17orf85physical
22365833
DDX17_HUMANDDX17physical
22365833
DDX5_HUMANDDX5physical
22365833
HNRPU_HUMANHNRNPUphysical
22365833
HNRL1_HUMANHNRNPUL1physical
22365833
RBM4_HUMANRBM4physical
22365833
HNRPD_HUMANHNRNPDphysical
22365833
HNRPF_HUMANHNRNPFphysical
22365833
HNRH1_HUMANHNRNPH1physical
22365833
HNRH3_HUMANHNRNPH3physical
22365833
IL7RA_HUMANIL7Rphysical
23151878
HNRDL_HUMANHNRNPDLphysical
26344197
HSPB1_HUMANHSPB1physical
26344197
PDCD6_HUMANPDCD6physical
26344197
SC16A_HUMANSEC16Aphysical
26344197
STIP1_HUMANSTIP1physical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HNRH3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-216, AND MASS SPECTROMETRY.
Methylation
ReferencePubMed
"A post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand.";
Yague J., Vazquez J., Lopez de Castro J.A.;
Protein Sci. 9:2210-2217(2000).
Cited for: PROTEIN SEQUENCE OF 116-127, AND METHYLATION AT ARG-121.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216; SER-298 ANDTHR-314, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-216, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-296, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-296, AND MASSSPECTROMETRY.

TOP